Please login to the form below

Not currently logged in

Spectrum Pharmaceuticals supports Fusilev with digital marketing campaign

Campaign for cancer drug includes a new website, HCP education tools and resources, and live programmes

US-based Spectrum Pharmaceuticals has launched a digital marketing campaign for its colorectal cancer drug Fusilev (levoleucovorin).

Featuring a new website, healthcare professional (HCP)educational tools, and live peer-to-peer educational programmes, the campaign will be aimed at oncologists, nurses, office practice managers and pharmacists.

"Strong commercial support for Fusilev has been rewarded by increased market penetration and sustained customer loyalty," said Rajesh Shrotriya, chairman, chief executive officer, and president of Spectrum Pharmaceuticals.

“We believe this campaign will continue to raise awareness of the Fusilev brand as well as grow the folate analog market."

20th August 2012


Featured jobs

Subscribe to our email news alerts


Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...